Peritoneal metastasis
Spread across the lining of the abdomen, the most common way stomach cancer recurs and the hardest to treat.
Present in ~30% at diagnosis and the leading site of relapse after gastrectomy. Poorly imaged (CT misses low-volume disease; staging laparoscopy is standard), poorly penetrated by systemic drugs. Intraperitoneal paclitaxel (PHOENIX-GC), HIPEC, and PIPAC are under evaluation; CLDN18.2 CAR-T shows activity.
Pages like this
not linked directly; found by shared links- ProductMitomycin C
Shares Appendiceal cancer and pseudomyxoma peritonei, HIPEC / PIPAC (intraperitoneal chemotherapy), Gastric & gastro-oesophageal junction cancer.
- TermHIPEC (hyperthermic intraperitoneal chemotherapy)
Shares HIPEC / PIPAC (intraperitoneal chemotherapy), Ovarian cancer, Gastric & gastro-oesophageal junction cancer, Colorectal cancer.
- InstitutionFirst Affiliated Hospital of Sun Yat-sen University
Shares HIPEC / PIPAC (intraperitoneal chemotherapy), Gastric & gastro-oesophageal junction cancer, Colorectal cancer.
- ProductCAPOX (capecitabine, oxaliplatin)
Shares Appendiceal cancer and pseudomyxoma peritonei, Gastric & gastro-oesophageal junction cancer, Colorectal cancer.
- PairingHIPEC at interval cytoreductive surgery
Shares HIPEC / PIPAC (intraperitoneal chemotherapy), Ovarian cancer.
- TrialOVHIPEC-1
Shares HIPEC / PIPAC (intraperitoneal chemotherapy), Ovarian cancer.
- TermIntraperitoneal (IP) chemotherapy
Shares HIPEC / PIPAC (intraperitoneal chemotherapy), Ovarian cancer, Gastric & gastro-oesophageal junction cancer.
- ProductOxaliplatin
Shares Appendiceal cancer and pseudomyxoma peritonei, Gastric & gastro-oesophageal junction cancer, Colorectal cancer.